Brimonidine
CAS 59803-98-4 5 FDA-DMF suppliersSmall Molecule
Overview
Brimonidine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL844).
API suppliers (7)
Suppliers of Brimonidine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- INDOCO REMEDIES LTD1 active DMF
- CENTAUR PHARMACEUTICALS PVT LTDIndia1 active DMF
- FDC LimitedIndia1 active DMF
- INDOCO REMEDIES LTD1 active DMF
- FDC LimitedIndia1 active DMF
- INDOCO REMEDIES LTD1 active DMF
- CENTAUR PHARMACEUTICALS PVT LTDIndia1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (25 approved US products), the latest listed US patent on Brimonidine expires 12 Jun 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
- Canonical SMILES
- C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
- InChIKey
- XYLJNLCSTIOKRM-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.